Detalhe da pesquisa
1.
Seasonal coronavirus-specific B cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19.
J Clin Invest
; 131(21)2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34499051